„TDF“

Suchergebnisse

116 Treffer

• Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review
  Birken, Sarah A. ; Powell, Byron J. ; Presseau, Justin ; Kirk, M. Alexis ; Lorencatto, Fabiana ; Gould, Natalie J. ; Shea, Christopher M. ; Weiner, Bryan J. ; Francis, Jill J. ; Yu, Yan ; Haines, Emily ; Damschroder, Laura J.
• Identifying the barriers and enablers for a triage, treatment, and transfer clinical intervention to manage acute stroke patients in the emergency department: a systematic review using the theoretical domains framework (TDF)
  Craig, Louise E. ; McInnes, Elizabeth ; Taylor, Natalie ; Grimley, Rohan ; Cadilhac, Dominique A. ; Considine, Julie ; Middleton, Sandy
• Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations
  Nobre, Carmen F. ; Newman, Matthew J. ; DeLisa, Anne ; Newman, Pauline
• Efficacy and safety of transdermal fentanyl (TDF) in treatment of pain caused by interventional embolization therapy
  Zhu, Xu ; Yang, Ren-jie ; Chen, Hui
• Dual antiretroviral therapy with tenofovir (TDF) and darunavir/ritonavir (DRV/RTV) in an HIV-1 positive patient: a case report, review, and meta-analysis of the literature on dual treatment strategies using protease inhibitors in combination with an NRTI
  Höring, S. ; Löffler, B. ; Pletz, M. W. ; Rößler, S. ; Weis, S. ; Schleenvoigt, B. T.
• Co-Infection VIH/VHB et traitement – Réponse immuno-virologique chez les patients co-infectés VIH/VHB sous traitement à base de TDF+FTC/3TC au Burkina Faso
  Kansono, Célestine Bégniagoua ; Maiga, Almoustapha I. ; Bado, Guillaume 2018 Éditions universitaires européennes
• Using the Theoretical Domains Framework (TDF) to understand adherence to multiple evidence-based indicators in primary care: a qualitative study
  Lawton, Rebecca ; Heyhoe, Jane ; Louch, Gemma ; Ingleson, Emma ; Glidewell, Liz ; Willis, Thomas A. ; McEachan, Rosemary R. C. ; Foy, Robbie
• Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
  Sánchez, Carlos Alberto ; Medrano, José ; Labarga, Pablo ; Vispo, Eugenia ; Calviño, Aida ; Martín-Carbonero, Luz ; Barreiro, Pablo ; Soriano, Vicente
• Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption
  Labarga, Pablo ; Barreio, Pablo ; Sanchez, Carlos A. ; Medrano, José ; Vispo, Eugenia ; Fernandez, Jose Vicente ; Blanco, Francisco ; Gonzalez-Lahoz, Juan ; Soriano, Vicente
• Tolerance and viral resistance after single-dose nevirapine (NVP) and short-course of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) to prevent mother-to-child transmission (PMTCT) of HIV-1: the TEmAA ANRS 12109 phase II trial, step 1
  Arrivé, Elise ; Blanche, Stéphane ; Chaix, Marie-Laure ; Nerrienet, Eric ; Rouzioux, Christine ; McIntyre, James ; Gray, Glenda ; Coffie, Patrick ; Sim, Kruy Leang ; Ekouevi, Didier ; Dabis, François
• TDF (Theoretical Domain Framework): how inclusive are TDF domains and constructs compared to other tools for assessing barriers to change?
  Sarmast, Hamideh ; Mosavianpour, Mirkaber ; Collet, Jean-Paul ; Kissoon, Niranjan
• Anesthesiologists’ and surgeons’ perceptions about routine pre-operative testing in low-risk patients: application of the Theoretical Domains Framework (TDF) to identify factors that influence physicians’ decisions to order pre-operative tests
  Patey, Andrea M. ; Islam, Rafat ; Francis, Jill J. ; Bryson, Gregory L. ; Grimshaw, Jeremy M.
• Error improvement of temporal discretization in TDFEM for electromagnetic analysis
  He, Xiaoxiang ; Li, Hao ; Zhou, Yonggang
• Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug
  Billaud, E. ; Lacombe, JM ; Abgrall, A. ; Ghosn, J. ; Launay, O. ; Livrozet, JM ; Meynard, JL ; Pavie, J. ; Costagliola, D.
• The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
  Cassetti, I. ; Etzel, A. ; Madruga, JV ; Suleiman, JM ; Zhou, Y. ; Rhee, M. ; Warren, DR
• Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
  DeJesus, E. ; Mills, A. ; Bhatti, L. ; Conner, C. ; Storfer, S.
• Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
  Cooper, V. ; Horne, R. ; Ewan, J.
• HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
  Baran, RW ; Dietz, B. ; Fredrick, LM ; Tian, M. ; Podsadecki, T.
• 5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
  Lazzarin, A. ; Johnson, M. ; Ribera, E. ; Weitner, L. ; Chen, SS ; Warren, DR
• Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART
  Uglietti, A. ; Gervasoni, C. ; Gabrielli, E. ; Di Giambenedetto, S. ; Cauda, R. ; Esposito, R. ; Grima, P. ; Di Perri, G. ; Maserati, R. ; Galli, M.